(Q36526925)

14 August 2017

1 reference

title

Non-steroid anti-inflammatory drug associated ulcer: epidemiology, causation and treatment (English)

1 reference

14 August 2017

Non-steroidal anti-inflammatory drug associated ulcer: Epidemiology, causation and treatment (English)

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

28 October 2022

1 reference

5

N. Yeomans

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681960

28 October 2022

author name string

M. J. Langman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681960

28 October 2022

P. Brooks

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681960

28 October 2022

C. J. Hawkey

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681960

28 October 2022

F. Silverstein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681960

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1681960

28 October 2022

publication date

1 September 1991

1 reference

full work available at URL

14 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1746.1991.tb00885.x

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.1991.tb00885.x/fullpdf

28 October 2022

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Journal of Gastroenterology and Hepatology

28 October 2022

published in

1 reference

14 August 2017

volume

6

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

442-449

1 reference

Peptic ulcer and non-steroidal anti-inflammatory agents

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Environmental factors in aetiology of chronic gastric ulcer: a case control study of exposure variables before the first symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Non-steroidal anti-inflammatory drugs and peptic ulcer perforation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Aspirin, paracetamol, and haematemesis and melaena

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Mechanisms underlying gastric mucosal damage induced by indomethacin and bile-salts, and the actions of prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Oxygen radicals: mediators of gastrointestinal pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Subepithelial hemorrhages and erosions of human stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

21 January 2018

Aspirin and the stomach

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Incidence of Gastric Lesions in Patients with Rheumatic Disease on Chronic Aspirin Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Reduction of endoscopically assessed acute aspirin-induced gastric mucosal injury with cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Nonsteroidal anti-inflammatory drugs--another look

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

FDA Arthritis Advisory Committee meeting: postmarketing surveillance of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND HOSPITAL ADMISSION FOR PERFORATED PEPTIC ULCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1991.TB00885.X

Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Non-steroidal anti-inflammatory drugs and peptic ulcers

28 October 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids

28 October 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center

28 October 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations

28 October 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Aspirin and bleeding peptic ulcers in the elderly

28 October 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other nonnarcotic analgesics

28 October 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

The two-component mucous barrier; its activity in protecting the gastroduodenal mucosa against peptic ulceration

28 October 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Cytoprotection by prostaglandins in rats

28 October 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Prostaglandin protection of human isolated gastric glands against indomethacin and ethanol injury. Evidence for direct cellular action of prostaglandin

28 October 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Effects of "loop" diuretics on ion transport by dog tracheal epithelium

28 October 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa

28 October 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

The mucoid cap over superficial gastric damage in the rat. A high-pH microenvironment dissipated by nonsteroidal antiinflammatory drugs and endothelin

28 October 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Evidence that adaptive cytoprotection in rats is not mediated by prostaglandins.

28 October 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

An analysis of the gastro-intestinal side-effects of non-steroidal anti-inflammatory drugs, with particular reference to comparative studies in man and laboratory species

28 October 2022

40

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Aspirin-induced ultrastructural changes in human gastric mucosa: correlation with potential difference

28 October 2022

42

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Gastric adaptation occurs with aspirin administration in man.

28 October 2022

45

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Gastric adaptation. Studies in humans during continuous aspirin administration

28 October 2022

46

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

28 October 2022

50

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Gastrointestinal Blood Loss during Prolonged Aspirin Administration

28 October 2022

57

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Cimetidine for peptic ulcer in patients with arthritis

28 October 2022

59

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

The influence of cimetidine on peptic ulcer in patients with arthritis taking anti-inflammatory drugs

28 October 2022

60

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Peptic ulcer in rheumatoid arthritis

28 October 2022

61

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

28 October 2022

62

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Prophylactic and therapeutic role of rioprostil in NSAIDs induced gastroduodenal lesions

28 October 2022

65

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

28 October 2022

67

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

28 October 2022

68

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Rising frequency of ulcer perforation in elderly people in the United Kingdom

28 October 2022

72

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage

28 October 2022

76

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans

28 October 2022

77

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.1991.TB00885.X

28 October 2022

Identifiers

1 reference

release_dozqijt43bhhvolyuq2r6reklm

14 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dozqijt43bhhvolyuq2r6reklm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference